RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 901–1,000 of 1,027
Yamashita, S., Hashimoto, M., Haque, A. M., Nakagawa, K., Kinoshita, M., Shido, O., & Miyazawa, T. (2017) · Lipids · doi:10.1007/s11745-017-4260-3 · Cited by 58
Yamada, A., Akimoto, H., Kagawa, S., Guillemin, G. J., & Takikawa, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06175.x · Cited by 58
Matsui, T., Ramasamy, K., Ingelsson, M., Fukumoto, H., Conrad, C., Frosch, M. P., Irizarry, M. C., Yuan, J., & Hyman, B. T. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229238.05748.12 · Cited by 58
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain
Riederer, P. F., & Hoyer, S. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0591-6 · Cited by 62
“sion into the cell as AGE does (Yan et al., 1996).”
BackgroundInfluentialCellular cofactors potentiating induction of stress and cytotoxicity by amyloid β-peptide
Yan, S. D., Roher, A. E., Chaney, M., Zloković, B. V., Schmidt, A. M., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00041-7 · Cited by 68
Self-citationApoptosis, Neurotrophic Factors and Neurodegeneration
Dragunow, M., MacGibbon, G. A., Lawlor, P. A., Butterworth, N. J., Connor, B. J., Henderson, C. E., Walton, M. R., Woodgate, A.-M., Hughes, P. E., & Faull, R. L. M. (1997) · Reviews in the Neurosciences · doi:10.1515/revneuro.1997.8.3-4.223 · Cited by 64
Singh, H., & Agrawal, D. K. (2022) · Drug Development Research · doi:10.1002/ddr.21971 · Cited by 57
“…C2) on RAGE, it can bind to the diverse classes of ligands, including AGEs, S100 calcium‐binding proteins, amyloid‐β, HMGB1, and so forth (Chavakis et al., 2003; Hofmann et al., 1999; Hori et al., 1995; Orlova et al., 2007; Santilli et al., 2009; Schmidt et al., 2000; Yan et al., 1996) (Figure 2).”
BackgroundWątroba, M., Grabowska, A. D., & Szukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210069 · Cited by 71
Prasanth, M. I., Sivamaruthi, B. S., Cheong, C. S. Y., Verma, K., Tencomnao, T., Brimson, J. M., & Prasansuklab, A. (2024) · Antioxidants · doi:10.3390/antiox13050606 · Cited by 71
Protein aging hypothesis of Alzheimer disease
Orpiszewski, J., Schormann, N., Kluve‐Beckerman, B., Liepnieks, J. J., & Benson, M. D. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1255 · Cited by 63
“The extracellular receptor RAGE of the immunoglobulin superfamily is one of these proteins that mediate oxidative stress and neurotoxicity (63).”
BackgroundHypertension and Related Factors in the Etiology of Alzheimer's Disease
SKOOG, I., & GUSTAFSON, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04796.x · Cited by 57
Alzheimer's disease therapeutic research: the path forward
Aisen, P. S. (2009) · Alzheimer s Research & Therapy · doi:10.1186/alzrt2 · Cited by 57
Cui, L., Cai, Y., Cheng, W., Liu, G., Zhao, J., Cao, H., Tao, H., Wang, Y., Yin, M., Liu, T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9783-8 · Cited by 59
“Aβ/RAGE signaling has been reported to perturb the APP pathway and to induce neuroinflammation, ultimately impairing neuronal function and contributing to the pathogenesis of AD [27–30].”
BackgroundLodeiro, M., Puerta, E., Ismail, M.-A.-M., Rodriguez-Rodriguez, P., Rönnbäck, A., Codita, A., Parrado-Fernandez, C., Maioli, S., Gil-Bea, F., Merino-Serrais, P., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw073 · Cited by 57
RAGE Enhances TLR Responses through Binding and Internalization of RNA
Bertheloot, D., Naumovski, A. L., Langhoff, P., Horvath, G. L., Jin, T., Xiao, T. S., Garbi, N., Agrawal, S., Kolbeck, R., & Latz, E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502169 · Cited by 57
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro
Cuevas, E., Rosas-Hernández, H., Burks, S. M., Ramirez-Lee, M. A., Guzmán, A., Imam, S. Z., Ali, S. F., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00447-8 · Cited by 60
Schraml, P., Bendik, I., & Ludwig, C. U. (1997) · PubMed · Cited by 57
Kurt, M. A., Davies, D. C., & Kidd, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7096 · Cited by 69
LaRue, B., Hogg, E., Sagare, A. P., Jovanovic, S. S., Maness, L. M., Maurer, C. R., Deane, R., & Zloković, B. V. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.04.026 · Cited by 64
β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices
Kabogo, D., Rauw, G. A., Amritraj, A., Baker, G. B., & Kar, S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.009 · Cited by 64
Mattson, M. P., & Rydel, R. E. (1996) · Nature · doi:10.1038/382674a0 · Cited by 57
Neuron Specific Toxicity of Oligomeric Amyloid-β: Role for JUN-Kinase and Oxidative Stress
Ebenezer, P. J., Weidner, A. M., LeVine, H., Markesbery, W. R., Murphy, M. P., Zhang, L., Dasuri, K., Fernandez-Kim, S. O., Bruce-Keller, A. J., Gavilán, E., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101161 · Cited by 58
Song, Z., Xie, X., Chen, Y., Zhang, B., Li, X., Yang, Y., Mo, W., Zhang, J., & Xu, D. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.024 · Cited by 67
Sherva, R., Baldwin, C. T., Inzelberg, R., Vardarajan, B., Cupples, L. A., Lunetta, K., Bowirrat, A., Naj, A., Pericak-Vance, M., Friedland, R. P., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100714 · Cited by 56
“Among the top results from the autozygosity mapping analyses, the gene with the most obvious biological link to AD is AGER which encodes a receptor for the amyloid- (A ) peptide whose expression is greatly increased in AD patients, especially in neurons proximal to deposits of A peptide and neurofibrillary tangles [40…”
HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin
András, I. E., Eum, S. Y., Huang, W., Zhong, Y., Hennig, B., & Toborek, M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.11.004 · Cited by 56
“RAGE is able to bind both Aβ monomers and fibrils (Yan et al., 1996).”
BackgroundMarkoutsa, E., Παπαδιά, Κ., Clemente, C., Flores, O., & Antimisiaris, S. G. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.006 · Cited by 67
Sambamurthy, N., Leme, A. S., Oury, T. D., & Shapiro, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118979 · Cited by 65
Origlia, N., Criscuolo, C., Arancio, O., Yan, S. S., & Domenici, L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0141-14.2014 · Cited by 56
“Interestingly, RAGE (Receptor for Advanced Glycation Endproducts) expression changes in neuronal and non-neuronal cells under ischemic conditions (Pichiule et al., 2007; Zhai et al., 2008) and AD (Yan et al., 1996).”
BackgroundResultSelf-citationMazzitelli, S., Xu, P., Ferrer, I., Davis, R. J., & Tournier, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4491-11.2011 · Cited by 65
“Furthermore, a positive-feedback loop by which oxidative stress produced following the interaction of A with the receptor for advanced glycation endproducts (RAGE) increases RAGE expression, thereby enhancing A neurotoxicity, has been suggested (Yan et al., 1996).”
BackgroundInfluentialMori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.762658 · Cited by 58
“Oxidative stress also contributes to AD pathogenesis (60, 61), and both OG and FA have anti-oxidant and free radical scavenging properties (14, 62).”
BackgroundRisk factors for Azheimer’s disease during aging. Impacts of glucose/energy metabolism
Hoyer, S. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_18 · Cited by 55
Potential neurotoxic activity of diverse molecules released by microglia
Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 53
Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis
Singh, S., Siva, B. V., & Ravichandiran, V. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10063-x · Cited by 58
Dual role of microglia in neuroinflammation and neurodegenerative diseases
Ajoolabady, A., Kim, B., Abdulkhaliq, A. A., Ren, J. T., Bahijri, S., Tuomilehto, J. O., Borai, A., Khan, J., & Praticò, D. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107133 · Cited by 70
Park, S. J., Kleffmann, T., & Hessian, P. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241281 · Cited by 60
RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study
Wang, P., Huang, R., Lu, S., Xia, W., Cai, R., Sun, H., & Wang, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145521 · Cited by 54
An, F.-M., Chen, S., Xu, Z., Yin, L., Wang, Y., Liu, A.-R., Yao, W.-B., & Gao, X.-D. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.023 · Cited by 59
Yamagishi, S., Nakamura, K., Inoue, H., Kikuchi, S., & Takeuchi, M. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.01.016 · Cited by 62
V domain of RAGE interacts with AGEs on prostate carcinoma cells
Allmen, E. U., Koch, M., Fritz, G., & Legler, D. F. (2008) · The Prostate · doi:10.1002/pros.20736 · Cited by 55
Takeda, A., Wakai, M., Niwa, H., Dei, R., Yamamoto, M., Li, M., Goto, Y., Yasuda, T., Nakagomi, Y., Watanabe, M., et al. (2001) · Acta Neuropathologica · doi:10.1007/s004010000256 · Cited by 57
“Recently, it was documented that a receptor for AGEs (RAGE) is also a specific cell-surface acceptor for Aβ, and that RAGE is involved in Aβ-mediated toxicity for neuronal cells [ 21 ].”
BackgroundImpact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 69
“, 2014) Previous studies have shown that pericytes also facilitate transmigration of neutrophils through upregulation of ICAM1 and RAGE receptors in AD brains (Yan et al., 1996; Wilhelmus et al., 2007; Zenaro et al., 2015).”
Lue, L.-F., Walker, D. G., Jacobson, S., & Sabbagh, M. (2009) · Future Neurology · doi:10.2217/14796708.4.2.167 · Cited by 54
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 64
“death [24, 30].”
Abe, K., & Saitō, H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01421-3 · Cited by 54
Abbass, M. M. S., Korany, N. S., Salama, A., Dmytryk, J. J., & Safiejko‐Mroczka, B. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.06.007 · Cited by 59
HMGB1–RAGE signaling pathway in severe preeclampsia
Zhu, L., Zhang, Z., Zhang, L., Shi, Y., Qi, J., Chang, A., Gao, J., Feng, Y., & Yang, X. (2015) · Placenta · doi:10.1016/j.placenta.2015.08.006 · Cited by 62
Origlia, N., Capsoni, S., Cattaneo, A., Fang, F., Arancio, O., Yan, S. D., & Domenici, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1045 · Cited by 54
“RAGE (receptor for advanced glycation end-products) is a multiligand receptor of the immunoglobulin superfamily that functions as a cell surface binding site for Aβ [23].”
InfluentialSelf-citationGood, T. A., & Murphy, R. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15130 · Cited by 64
Bench-to-bedside review: High-mobility group box 1 and critical illness
Fink, M. P. (2007) · Critical Care · doi:10.1186/cc6088 · Cited by 57
Ma, L., & Nicholson, L. F. B. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.052 · Cited by 57
Manda, K., Ueno, M., & Anzai, K. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00507.x · Cited by 57
Stepanichev, M. Y., Zdobnova, I. M., Yakovlev, A. A., Onufriev, M. V., Lazareva, N. A., Zarubenko, I. I., & Gulyaeva, N. V. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10469 · Cited by 54
“Apoptosisinducing ability of A may be mediated by the interaction of the peptide with the free radical-related receptor for advanced glycation end products on neurons (Yan et al., 1996), and with the p75 neurotrophin receptor (Yaar et al.”
BackgroundResultInfluentialOxidized low density lipoprotein caused CNS neuron cell death
Sugawa, M., Ikeda, S., Kushima, Y., Takashima, Y., & Cynshi, O. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00468-x · Cited by 55
Murakami, K. (2014) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2014.940275 · Cited by 53
The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases
Armando Rojas, R., Lindner, C., Schneider, I., González, I., & Uribarri, J. (2024) · Biomolecules · doi:10.3390/biom14040412 · Cited by 67
“Since the pioneering work of Yan et al. that showed for the first time that amyloid-beta peptide is a ligand of RAGE, new research has shed light to the role of RAGE in AD [35].”
BackgroundMangalmurti, N. S., Chatterjee, S., Cheng, G., Andersen, E. S., Mohammed, A., Siegel, D. L., Schmidt, A. M., Albelda, S. Μ., & Lee, J. S. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02689.x · Cited by 59
Self-citationOhlmeier, S., Mazur, W., Salmenkivi, K., Myllärniemi, M., Bergmann, U., & Kinnula, V. L. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900128 · Cited by 56
Zhang, K., Lou, D., & Guan, Z. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.01.007 · Cited by 52
Amyloid-β (25–35) increases activity of neuronal NO-synthase in rat brain
Stepanichev, M. Y., Onufriev, M. V., Yakovlev, A. A., Khrenov, A. I., Peregud, D., Vorontsova, O. N., Лазарева, Н. А., & Gulyaeva, N. V. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.11.009 · Cited by 57
Adult human brain cell culture for neuroscience research
Gibbons, H. M., & Dragunow, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.002 · Cited by 58
AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?
Koyama, H., & Nishizawà, Y. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02298.x · Cited by 57
Brandenburg, L., Konrad, M., Wruck, C. J., Koch, T., Pufe, T., & Lucius, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.042 · Cited by 56
Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Twyman, L. J., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00510-x · Cited by 61
Increased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin Vitro
Hangaishi, M., Taguchi, J., Miyata, T., Ikari, Y., Togo, M., Hashimoto, Y., Watanabe, T., Kimura, S., Kurokawa, K., & Ohno, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8945 · Cited by 54
Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach
Schelke, M. W., Hackett, K., Chen, J. L., Shih, C., Shum, J., Montgomery, M. E., Chiang, G. C., Berkowitz, C., Seifan, A., Krikorian, R., et al. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13070 · Cited by 51
Passos, G. F., Figueiredo, C. P., Prediger, R. D., Silva, K. A. B. S., Siqueira, J. M., Duarte, F. S., Leal, P. C., Medeiros, R., & Calixto, J. Β. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.12.003 · Cited by 63
Association of the RAGE G82S polymorphism with Alzheimer’s disease
Daborg, J., von Otter, M., Sjölander, A., Nilsson, S., Minthon, L., Gustafson, D. R., Skoog, I., Blennow, K., & Zetterberg, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0437-0 · Cited by 51
“In addition, this protein has been implicated in several other aspects of AD pathology, such as inflammation, oxidative stress and transport of Ab across the blood–brain barrier (Deane et al. 2003; Schmidt et al. 2009; Yan et al. 1996).”
BackgroundMeneghini, V., Francese, M. T., Carraro, L., & Grilli, M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.06.005 · Cited by 55
Immortalized human microglial cell line: Phenotypic expression
Nagai, A., Mishima, S., Ishida, Y., Ishikura, H., Harada, T., Kobayashi, S., & Kim, S. U. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20478 · Cited by 51
“…microglia or human macrophage/monocyte revealed the increased cytokine release following Ab treatment (Araujo and Cotman, 1992b; Meda et al., 1995; Yan et al., 1996; Fiala et al., 1998), the response of microglia cell lines to Ab or Ab fragments is another important issue to be addressed for…”
BackgroundManagement of oxidative stress in the CNS: The many roles of glutathione
Juurlink, B. H. J. (1999) · Neurotoxicity Research · doi:10.1007/bf03033276 · Cited by 55
Nag, S., Yee, B. K., & Tang, F. M. K. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00196-3 · Cited by 60
“Indeed, oxidative stress is one mechanism whereby Ab (25-35, 1-40 or 1-42) is believed to induce neurodegeneration in AD [68,69].”
BackgroundStereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.
Ciccotosto, G., Tew, D., Drew, S., Smith, D. G., Johanssen, T., Lal, V., Lau, T., Perez, K., Curtain, C., Wade, J., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.018 · Cited by 48
Perrone, L., Sbai, O., Nawroth, P. P., & Bierhaus, A. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/734956 · Cited by 51
“The expression level of RAGE is high in rodent cortical neurons during the neonatal period [49], while its presence strongly decreases during maturity with few cortical neurons showing RAGE staining [50].”
BackgroundSelf-citationThe neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity
Li, E., Noda, M., Doi, Y., Parajuli, B., Kawanokuchi, J., Sonobe, Y., Takeuchi, H., Mizuno, T., & Suzumura, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-148 · Cited by 51
“RAGE is a surface molecule that directly interacts with Aβ and activates NFκB-mediated signaling pathways in microglia [42,43].”
BackgroundGenetics of inclusion‐body myositis
Needham, M., Mastaglia, F. L., & Garlepp, M. J. (2007) · Muscle & Nerve · doi:10.1002/mus.20766 · Cited by 52
Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain
Patel, A. N., & Jhamandas, J. H. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002134 · Cited by 43
Behzadfar, L., Abdollahi, M. R., Sabzevari, O., Hosseini, R., Salimi, A., Naserzadeh, P., Sharifzadeh, M. S., & Pourahmad, J. (2017) · Metallomics · doi:10.1039/c7mt00075h · Cited by 52
Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes
Bagge, S. L., Fotheringham, A. K., Leung, S. S., & Forbes, J. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21654 · Cited by 59
Cerebrovascular phenotypes in mouse models of Alzheimer’s disease
Szu, J. I., & Obenaus, A. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x21992462 · Cited by 50
“Compared with autopsy controls and early AD, brains from severe AD individuals displayed robust microvascular RAGE immunoreactivity in the hippocampus.(90,92,93) It is not surprising then, that the upregulation of RAGE can alter CBF.”
BackgroundOnyango, I. G., Tuttle, J. B., & Bennett, J. P. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.012 · Cited by 56
Juurlink, B. H. J. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y00-120 · Cited by 60
“…for AGEs (RAGE) has been characterized; it is comprised of a 45 kD membrane-spanning glycoprotein and an 80 kD lactoferrinlike protein (Thornalley 1998a). β-Amyloid peptide activation of RAGE has been implicated as part of the pathogenetic mechanism of Alzheimer’s disease (Yan et al. 1996).”
BackgroundMolecular and cellular mediators of Alzheimer's disease inflammation
Strohmeyer, R., & Rogers, J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3118 · Cited by 51
Amyloid precursor protein, copper and Alzheimer's disease
Multhaup, G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86907-7 · Cited by 57
Li, W., Chen, Q., Peng, C., Yang, D., Liu, S., Lv, Y., Jiang, L., Xu, S., & Li-hua, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010403 · Cited by 57
“Research utilizing specific antibodies has revealed that A β oligomers associate with the V domain, whereas A β aggregates bind to the C1 domain [124,125].”
CCR6: A Biomarker for Alzheimer's-like Disease in a Triple Transgenic Mouse Model
Subramanian, S., Ayala, P., Wadsworth, T. L., Harris, C. J., Vandenbark, A. A., Quinn, J. F., & Offner, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100852 · Cited by 50
“Chronically activated microglia release IL-1, IL-6, and TNF-α [3,4] and express receptors for A β oligomers triggering the release of cytokines, glutamate, and nitric oxide [5,6].”
Wang, Y., Yu, H., Pu, X., & Du, G. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0222-2 · Cited by 50
“RAGE has also been proposed to be a mediator for amyloid-β (Aβ) peptide neurotoxicity and to be responsible for pathogenic Aβ assembly in Alzheimer’s disease (Yan et al. 1996; Schmidt et al. 2001).”
BackgroundEffect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease
Lee, E., Eom, J.-E., Kim, H.-L., Baek, K. H., Jun, K.-Y., Kim, H., Lee, M., Mook‐Jung, I., & Kwon, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.12.003 · Cited by 56
Downregulation of LPR1 at the blood–brain barrier in streptozotocin-induced diabetic mice
Hong, H., Liu, L. P., Liao, J. M., Wang, T. S., Ye, F.-Y., Wu, J., Wang, Y. Y., Wang, Y., Li, Y. Q., & Long, Y. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.001 · Cited by 53
What is the role of the receptor for advanced glycation end products–ligand axis in liver injury?
Basta, G., Navarra, T., SIMONE, P. D., Turco, S. D., Gastaldelli, A., & Filipponi, F. (2011) · Liver Transplantation · doi:10.1002/lt.22306 · Cited by 52
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 58
“[117] Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al.”
BackgroundThe Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins
Yatime, L., Betzer, C., Jensen, R. K., Mortensen, S., Jensen, P. H., & Andersen, G. R. (2016) · Structure · doi:10.1016/j.str.2016.09.011 · Cited by 55
A Significant Role for the Heme Oxygenase-1 Gene in Endothelial Cell Cycle Progression
Kushida, T., Quan, S., Yang, L., Ikehara, S., Kappas, A., & Abraham, N. G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6403 · Cited by 54
Nassif, M., Hoppe, J. B., Santin, K., Frozza, R. L., Zamin, L. L., Simão, F., Horn, A. P., & Salbego, C. G. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.008 · Cited by 60
Pogocki, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1463 · Cited by 50
Wang, L., Li, S., & Jungalwala, F. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21578 · Cited by 50
Lipoprotein effects on aβ accumulation and degradation by microglia in vitro
Cole, G. M., Beech, W., Frautschy, S. A., Sigel, J., Glasgow, C., & Ard, M. D. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4<504::aid-jnr10>3.0.co;2-h · Cited by 48
“This deposited material would not contain ApoE consistent with data showing that the earliest diffuse deposits are not ApoE-positive (Lemere et al., 1996; Yan et al., 1996).”
BackgroundBlood-brain barrier integrity is the primary target of alcohol abuse
Wei, J., Dai, Y., Wen, W., Li, J., Ye, L. L., Xu, S., & Duan, D. D. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109400 · Cited by 58
Abdallah, I. M., Al-Shami, K. M., Yang, E., Wang, J., Guillaume, C., & Kaddoumi, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00005 · Cited by 53
Shaerzadeh, F., Motamedi, F., Minai‐Tehrani, D., & Khodagholi, F. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8272-8 · Cited by 53
“Also, it has been shown that Ab directly and indirectly interacts with signaling molecules to activate and/or inactivate intracellular cascades eventually leading to neuronal death (Morishima et al. 2001; Troy et al. 2000; Yan et al. 1996; Small et al. 2009).”
Receptor for advanced glycation endproducts and progressive kidney disease
Fukami, K., Taguchi, K., Yamagishi, S.-I., & Okuda, S. (2015) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0000000000000091 · Cited by 46
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.